This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Insurance Giant Showing Immunity to This Year's Market Volatility
by Bryan Hayes
This stock has bucked the downtrend of the market this year, displaying relatively low volatility.
Why Cigna (CI) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Cigna Corporation (CI) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Cigna (CI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cigna (CI) to Offer Low-Cost Health Plans in 11 Texas Counties
by Zacks Equity Research
Cigna (CI) expects the 2023 Open Enrollment Period to start on Nov 1 for Texas residents.
4 Stocks From the Finance Sector Crushing the S&P 500 in 2022
by Derek Lewis
Financial service companies, such as insurance firms, can see their profit margins expand in higher interest rate environments.
Is Cigna (CI) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cigna's (CI) New Pathwell Suite to Boost Efficiency, Lower Cost
by Zacks Equity Research
Cigna (CI) expects to bump up its Pathwell suite's availability throughout the next year.
Why Should You Retain Cigna (CI) in Your Portfolio Now?
by Zacks Equity Research
Cigna (CI) is aided by powerful segmental performances, solid demand for its Medicare plans, divestitures and solid cash-generating abilities.
Cigna (CI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Cigna (CI) closed at $282.55 in the latest trading session, marking a +1.78% move from the prior day.
Cigna (CI) Stock Moves -0.72%: What You Should Know
by Zacks Equity Research
Cigna (CI) closed the most recent trading day at $282.90, moving -0.72% from the previous trading session.
Cigna (CI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Cigna (CI) closed the most recent trading day at $290.35, moving +0.13% from the previous trading session.
Cigna's (CI) Arm Adds Five Digital Health Apps to Its Platform
by Zacks Equity Research
Cigna's (CI) unit bolsters its clinical platform Digital Health Formulary by including five on-line solutions, aiming to relieve people from chronic medical conditions.
Should Invesco S&P 500 Pure Value ETF (RPV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for RPV
Is Invesco S&P 500 Pure Value ETF (RPV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RPV
Cigna (CI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Cigna (CI) closed the most recent trading day at $292.84, moving +0.73% from the previous trading session.
Should IQ Chaikin U.S. Large Cap ETF (CLRG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for CLRG
Is IQ Chaikin U.S. Large Cap ETF (CLRG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for CLRG
Cigna (CI) to Widen Access to Individual Health Plans in 2023
by Zacks Equity Research
Cigna (CI) unveils enhanced individual and family health plans for its customers to opt for in the 2023 Open Enrollment Period. CI will enter newer counties and states to offer better health outcomes.
Cigna (CI) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Here is What to Know Beyond Why Cigna Corporation (CI) is a Trending Stock
by Zacks Equity Research
Cigna (CI) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here's How Much You'd Have If You Invested $1000 in Cigna a Decade Ago
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
The Zacks Analyst Blog Highlights Apple, Alibaba, Bristol-Myers Squibb, Tesla and Cigna
by Zacks Equity Research
Apple, Alibaba, Bristol-Myers Squibb, Tesla and Cigna are part of The Zacks top Analyst Blog.
Top Analyst Reports for Apple, Alibaba & Bristol-Myers Squibb
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including Apple Inc. (AAPL), Alibaba Group Holding Limited (BABA) and Bristol-Myers Squibb Company (BMY).
Lincoln (LNC) to Fuel Small-Cap Investment With LVIP Channing
by Zacks Equity Research
Lincoln National (LNC) expects Channing Capital's investment strategy to protect the investors from the downside while delivering significant gains.
All You Need to Know About Cigna (CI) Rating Upgrade to Buy
by Zacks Equity Research
Cigna (CI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.